RW
KZR

RVW Wealth’s Kezar Life Sciences KZR Stock Holding History

RVW Wealth’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,377
Closed -$18.4K – 154
2024
Q3 		$18.4K Hold
2,377
– – ﹤0.01% 154
2024
Q2 		$14.3K Buy
+2,377
New +$18.1K ﹤0.01% 149
2024
Q1 		– Sell
-2,377
Closed -$22.5K – 149
2023
Q4 		$22.5K Hold
2,377
– – ﹤0.01% 141
2023
Q3 		$28.3K Buy
+2,377
New +$42.1K ﹤0.01% 284

Other funds holding KZR

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

RVW Wealth's KZR Position: Q4 2024 in Review

RVW Wealth sold out of Kezar Life Sciences (KZR) in Q4 2024, closing a stake of 2,377 shares — an estimated $18.4K sold.

RVW Wealth first reported a position in KZR in Q3 2023 and held it in 4 quarters. The position peaked at $28.3K in Q3 2023. 43 funds tracked by Wall St. Rank hold KZR as of Q4 2024.

  • RVW Wealth reported no remaining Kezar Life Sciences position as of Q4 2024 after selling out during the quarter.
  • RVW Wealth sold 2,377 Kezar Life Sciences shares in Q4 2024, an estimated $18.4K.
  • RVW Wealth first reported a position in Kezar Life Sciences in Q3 2023 and held it in 4 quarters.
  • RVW Wealth's Kezar Life Sciences position peaked at $28.3K in Q3 2023.
  • 43 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q4 2024.

Based on RVW Wealth's 13F filing for Q4 2024, filed 23 Jan 2025.